VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
63,479
AK1,562
AL4,914
AR3,110
AS44
AZ12,730
CA54,886
CO10,464
CT7,347
DC1,568
DE1,561
FL33,514
FM3
GA12,508
GU74
HI2,078
IA4,130
ID2,361
IL18,091
IN22,023
KS4,061
KY6,276
LA4,395
MA13,121
MD11,272
ME2,858
MH8
MI16,697
MN10,689
MO8,360
MP30
MS2,487
MT2,035
NC14,437
ND1,184
NE2,562
NH2,717
NJ16,033
NM3,532
NV3,784
NY30,921
OH17,029
OK5,673
OR7,479
PA21,111
PR1,959
QM2
RI1,833
SC5,601
SD1,087
TN8,048
TX31,896
UT3,791
VA13,180
VI48
VT1,592
WA13,026
WI9,856
WV2,120
WY754
XB5
XL1
XV2

ID: 1572147
Sex: F
Age: 32
State: PA

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchiness; Nausea (all day); Headache; Sigificant arm pain; Redness; Swelling; Hard lump; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Sigificant arm pain), ERYTHEMA (Redness), SWELLING (Swelling), INDURATION (Hard lump) and PRURITUS (Itchiness) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event (No reported medical history). On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sigificant arm pain), ERYTHEMA (Redness), SWELLING (Swelling), INDURATION (Hard lump), NAUSEA (Nausea (all day)) and HEADACHE (Headache). On an unknown date, the patient experienced PRURITUS (Itchiness). On 09-Jan-2021, PAIN IN EXTREMITY (Sigificant arm pain), SWELLING (Swelling), INDURATION (Hard lump), NAUSEA (Nausea (all day)) and HEADACHE (Headache) had resolved. At the time of the report, ERYTHEMA (Redness) and PRURITUS (Itchiness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1572148
Sex: M
Age: 70
State: CO

Vax Date: 01/10/2021
Onset Date: 01/12/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: slight fever 99.8 F; soreness on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness on the injection site) and PYREXIA (slight fever 99.8 F) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical history was reported). Concomitant products included ATORVASTATIN CALCIUM, EZETIMIBE (STATIN EZ). On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE PAIN (soreness on the injection site). On an unknown date, the patient experienced PYREXIA (slight fever 99.8 F). On 13-Jan-2021, VACCINATION SITE PAIN (soreness on the injection site) outcome was unknown. At the time of the report, PYREXIA (slight fever 99.8 F) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: STATIN EZ

Current Illness:

ID: 1572149
Sex: F
Age:
State: FL

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: left arm became swollen; left arm is itching; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (left arm became swollen) and PRURITUS (left arm is itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The patient's past medical history included COPD and Shoulder deformity NOS. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced PERIPHERAL SWELLING (left arm became swollen) and PRURITUS (left arm is itching). At the time of the report, PERIPHERAL SWELLING (left arm became swollen) and PRURITUS (left arm is itching) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1572150
Sex: M
Age:
State:

Vax Date: 12/30/2020
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Temperature of 99.1; Not feeling well; Headaches; Muscle pain; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Temperature of 99.1), VACCINATION COMPLICATION (Not feeling well), HEADACHE (Headaches), MYALGIA (Muscle pain) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Temperature of 99.1), VACCINATION COMPLICATION (Not feeling well), HEADACHE (Headaches), MYALGIA (Muscle pain) and CHILLS (Chills). At the time of the report, PYREXIA (Temperature of 99.1), VACCINATION COMPLICATION (Not feeling well), HEADACHE (Headaches), MYALGIA (Muscle pain) and CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment medication was reported.

Other Meds:

Current Illness:

ID: 1572151
Sex: U
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm ache; shoulder ache; neck ache; A spontaneous report was received from a Consumer concerning an unknown patient of unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced arm ache,neck ache and shoulder aches. The patient's medical history was not provided. Concomitant medications history was not provided. On 15 Jan 2021 the patient received dose of mRNA-1273 (Lot number: unknown)for prophylaxis of COVID-19 infection. After the administration of vaccine the patient experienced ache,neck ache and shoulder aches. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the events experienced a ache,neck ache and shoulder aches was considered as unknown at th e time of the report .; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.

Other Meds:

Current Illness:

ID: 1572152
Sex: F
Age:
State: OH

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: vaccination site erythema; vaccination site swelling; injection site hard to the touch; vaccination site warmth; vaccination site pruritus; lymph nodes that were large and swollen near collar bone; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm pain), VACCINATION SITE ERYTHEMA (vaccination site erythema), VACCINATION SITE SWELLING (vaccination site swelling), VACCINATION SITE INDURATION (injection site hard to the touch) and VACCINATION SITE PRURITUS (vaccination site pruritus) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L204A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (arm pain). On 12-Jan-2021, the patient experienced LYMPHADENOPATHY (lymph nodes that were large and swollen near collar bone). On 14-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (vaccination site pruritus). On 15-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (vaccination site erythema), VACCINATION SITE SWELLING (vaccination site swelling), VACCINATION SITE INDURATION (injection site hard to the touch) and VACCINATION SITE WARMTH (vaccination site warmth). On 09-Jan-2021, VACCINATION SITE PAIN (arm pain) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (vaccination site erythema), VACCINATION SITE SWELLING (vaccination site swelling), VACCINATION SITE INDURATION (injection site hard to the touch), VACCINATION SITE PRURITUS (vaccination site pruritus), VACCINATION SITE WARMTH (vaccination site warmth) and LYMPHADENOPATHY (lymph nodes that were large and swollen near collar bone) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Last night (14JAN2021) before going to bed, she noticed her arm near the injection was itching and red. This morning (15JAN2021) the area became round as a softball, hard to the touch, much bigger, itchy, and hot. No history of concomitant medications were taken by the patient. Patient was able to get hold of health department who suggested her using heat, cold and ice in the effected area. She has not started following the suggestion which health department gave.

Other Meds:

Current Illness:

ID: 1572153
Sex: F
Age:
State:

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm numbness; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Arm numbness), NAUSEA (Nausea) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 15-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced HYPOAESTHESIA (Arm numbness), NAUSEA (Nausea) and HEADACHE (Headache). At the time of the report, HYPOAESTHESIA (Arm numbness), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported. No treatment information provided.

Other Meds:

Current Illness:

ID: 1572154
Sex: F
Age:
State:

Vax Date: 12/30/2020
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: side effects that have lasted ten days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects that have lasted ten days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 30-Dec-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects that have lasted ten days). At the time of the report, VACCINATION COMPLICATION (side effects that have lasted ten days) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication reported. Treatment for the event included was not provided.

Other Meds:

Current Illness:

ID: 1572155
Sex: M
Age: 77
State:

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dizzy and lightheaded; opposite side shoulder he received the vaccine was sore; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy and lightheaded) and ARTHRALGIA (opposite side shoulder he received the vaccine was sore) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced DIZZINESS (dizzy and lightheaded) and ARTHRALGIA (opposite side shoulder he received the vaccine was sore). On 15-Jan-2021, DIZZINESS (dizzy and lightheaded) and ARTHRALGIA (opposite side shoulder he received the vaccine was sore) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported. Treatment included Heat

Other Meds:

Current Illness:

ID: 1572156
Sex: F
Age: 87
State: CA

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Painful, warm touch, red swollen rump at the site injection; Painful, warm touch, red swollen rump at the site injection; Painful, warm touch, red swollen rump at the site injection; Painful, warm touch, red swollen rump at the site injection; Painful, warm touch, red swollen rump at the site injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Painful, warm touch, red swollen rump at the site injection), VACCINATION SITE SWELLING (Painful, warm touch, red swollen rump at the site injection), VACCINATION SITE PAIN (Painful, warm touch, red swollen rump at the site injection), VACCINATION SITE ERYTHEMA (Painful, warm touch, red swollen rump at the site injection) and VACCINATION SITE INDURATION (Painful, warm touch, red swollen rump at the site injection) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. No Medical History information was reported. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Painful, warm touch, red swollen rump at the site injection), VACCINATION SITE SWELLING (Painful, warm touch, red swollen rump at the site injection), VACCINATION SITE PAIN (Painful, warm touch, red swollen rump at the site injection), VACCINATION SITE ERYTHEMA (Painful, warm touch, red swollen rump at the site injection) and VACCINATION SITE INDURATION (Painful, warm touch, red swollen rump at the site injection). At the time of the report, VACCINATION SITE WARMTH (Painful, warm touch, red swollen rump at the site injection), VACCINATION SITE SWELLING (Painful, warm touch, red swollen rump at the site injection), VACCINATION SITE PAIN (Painful, warm touch, red swollen rump at the site injection), VACCINATION SITE ERYTHEMA (Painful, warm touch, red swollen rump at the site injection) and VACCINATION SITE INDURATION (Painful, warm touch, red swollen rump at the site injection) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient applied ice and hydrocortisone for treatment, but the symptoms persisted.

Other Meds:

Current Illness:

ID: 1572157
Sex: F
Age:
State:

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swelling and warmness at the injection site, and swelling again at day 8; swelling and warmness at the injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE WARMTH (swelling and warmness at the injection site ) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced VACCINATION SITE WARMTH (swelling and warmness at the injection site ). On 10-Jan-2021, VACCINATION SITE WARMTH (swelling and warmness at the injection site ) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. On 09JAN2021 consumer took first dose of Moderna COVID 19 vaccine last Saturday and she got swelling and warmness at injection site. But it went away on second day but on 16JAN2021 after 8 days her arm is swollen again. Treatment information not provided.

Other Meds:

Current Illness:

ID: 1572158
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; it's a little red; there's a welt and now there's a second one; Itching in the area; it's a little hot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm), VACCINATION SITE ERYTHEMA (it's a little red), VACCINATION SITE SWELLING (there's a welt and now there's a second one), VACCINATION SITE PRURITUS (Itching in the area) and VACCINATION SITE WARMTH (it's a little hot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore arm), VACCINATION SITE ERYTHEMA (it's a little red), VACCINATION SITE SWELLING (there's a welt and now there's a second one), VACCINATION SITE PRURITUS (Itching in the area) and VACCINATION SITE WARMTH (it's a little hot). At the time of the report, VACCINATION SITE PAIN (Sore arm), VACCINATION SITE ERYTHEMA (it's a little red), VACCINATION SITE SWELLING (there's a welt and now there's a second one), VACCINATION SITE PRURITUS (Itching in the area) and VACCINATION SITE WARMTH (it's a little hot) outcome was unknown. Treatment for the events were not reported.

Other Meds:

Current Illness:

ID: 1572159
Sex: F
Age: 64
State: OH

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchy; Swelling at the injection site; Redness at the injection site; Mild pain and tenderness at the injection site; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PRURITUS (Itchy) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. Concomitant products included HYDROCHLOROTHIAZIDE, ATORVASTATIN, LORATADINE, UBIDECARENONE (QUNOL LIQUID COQ10), CALCIUM CARBONATE, COLECALCIFEROL (CALTRATE 600 + D), MULTI VITAMIN ONE A DAY, TRIAMCINOLONE ACETONIDE (NASACORT) and APOAEQUORIN, COLECALCIFEROL (PREVAGEN [APOAEQUORIN;COLECALCIFEROL]) for an unknown indication. On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itchy). At the time of the report, VACCINATION SITE PRURITUS (Itchy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment for the events included diphenhydramine.

Other Meds: HYDROCHLOROTHIAZIDE; ATORVASTATIN; LORATADINE; QUNOL LIQUID COQ10; CALTRATE 600 + D; MULTI VITAMIN ONE A DAY; NASACORT; PREVAGEN [APOAEQUORIN;COLECALCIFEROL]

Current Illness:

ID: 1572160
Sex: F
Age: 55
State:

Vax Date: 12/30/2020
Onset Date: 12/30/2020
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: knot/swelling/swollen lymph node above the L clavicle; Left arm hurt; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (Left arm hurt) and LYMPHADENOPATHY (knot/swelling/swollen lymph node above the L clavicle) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20(?)) for COVID-19 vaccination. No medical history was provided by the reporter. On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced VACCINATION SITE PAIN (Left arm hurt). On 11-Jan-2021, the patient experienced LYMPHADENOPATHY (knot/swelling/swollen lymph node above the L clavicle). On 02-Jan-2021, VACCINATION SITE PAIN (Left arm hurt) had resolved. At the time of the report, LYMPHADENOPATHY (knot/swelling/swollen lymph node above the L clavicle) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572161
Sex: F
Age: 35
State: TX

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: injection site swelling; Hurts; Fever; chills; Headache; Feels cold; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE SWELLING (injection site swelling), VACCINATION SITE PAIN (Hurts), PYREXIA (Fever), CHILLS (chills) and HEADACHE (Headache) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE SWELLING (injection site swelling), VACCINATION SITE PAIN (Hurts), PYREXIA (Fever), CHILLS (chills), HEADACHE (Headache) and FEELING COLD (Feels cold). At the time of the report, VACCINATION SITE SWELLING (injection site swelling), VACCINATION SITE PAIN (Hurts), PYREXIA (Fever), CHILLS (chills), HEADACHE (Headache) and FEELING COLD (Feels cold) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Jan-2021, Body temperature: 99.7 f degree Celsius (High) high. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No treatment medication was reported.

Other Meds:

Current Illness:

ID: 1572162
Sex: F
Age:
State:

Vax Date: 01/14/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Right arm hurts; Right shoulder hurts; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Right arm hurts) and ARTHRALGIA (Right shoulder hurts) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Right arm hurts) and ARTHRALGIA (Right shoulder hurts). At the time of the report, VACCINATION SITE PAIN (Right arm hurts) and ARTHRALGIA (Right shoulder hurts) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information not reported. No concomitant medication reported.

Other Meds:

Current Illness:

ID: 1572163
Sex: F
Age:
State: NM

Vax Date: 01/07/2021
Onset Date: 01/14/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Site of injcetion became red that spreads from top of her shoulder to her biceps; Site of injection is itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Site of injcetion became red that spreads from top of her shoulder to her biceps) and VACCINATION SITE PRURITUS (Site of injection is itching) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included ARNICA MONTANA (ARNICA (PLANTA TOTA) "WELEDA") for an unknown indication. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Site of injcetion became red that spreads from top of her shoulder to her biceps) and VACCINATION SITE PRURITUS (Site of injection is itching). At the time of the report, VACCINATION SITE ERYTHEMA (Site of injcetion became red that spreads from top of her shoulder to her biceps) and VACCINATION SITE PRURITUS (Site of injection is itching) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Patient used Benadryl and cortisone cream for treatment.

Other Meds: ARNICA (PLANTA TOTA) "WELEDA"

Current Illness:

ID: 1572164
Sex: M
Age: 72
State: NY

Vax Date: 01/11/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: it hurts; it's itchy; My arm is turning red, it appears to be spreading; It's hot; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (It's hot) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. No Medical History information was reported. On 11-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (It's hot). At the time of the report, VACCINATION SITE WARMTH (It's hot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient's primary care physician told him to take Benadryl and put cortisone ointment on the injection site.

Other Meds:

Current Illness:

ID: 1572165
Sex: F
Age: 40
State: FL

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swollen tongue,the tongue is a little sore,I woke up with a scalloped tongue; swollen tongue,the tongue is a little sore,I woke up with a scalloped tongue; arm was sore; a slight headache that went on and off for 10 minutes then no more headaches that happened; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TONGUE DISCOMFORT (swollen tongue,the tongue is a little sore,I woke up with a scalloped tongue) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. Concurrent medical conditions included Allergy to plants (patient had a swollen tongue when eating spinach and now she has an anaphylaxis reaction to spinach.). On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced TONGUE DISCOMFORT (swollen tongue,the tongue is a little sore,I woke up with a scalloped tongue). At the time of the report, TONGUE DISCOMFORT (swollen tongue,the tongue is a little sore,I woke up with a scalloped tongue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications taken by the patient were not provided. Treatment activities for event was done with diphenhydramine.

Other Meds:

Current Illness:

ID: 1572166
Sex: M
Age:
State:

Vax Date:
Onset Date: 01/16/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: heart is beating fast; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (heart is beating fast) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included COVID-19 (Patient is reported to have a long covid syndrome since he cant breath good for past month.). On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced HEART RATE INCREASED (heart is beating fast). At the time of the report, HEART RATE INCREASED (heart is beating fast) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications taken by the patient were not provided. Treatment activities for event was unknown.

Other Meds:

Current Illness:

ID: 1572167
Sex: F
Age:
State: NJ

Vax Date: 12/29/2020
Onset Date: 12/30/2020
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: High fever; Chills; Swelling; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20a) for COVID-19 vaccination. The patient's past medical history included COVID-19 on 06-Apr-2020. Concurrent medical conditions included Blood pressure. Concomitant products included METFORMIN, LEVOTHYROXINE, ATORVASTATIN, OLMESARTAN, MELOXICAM (MELOXICAN) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication. On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds: METFORMIN; LEVOTHYROXINE; ATORVASTATIN; OLMESARTAN; MELOXICAN; MULTIVITAMIN [VITAMINS NOS]

Current Illness:

ID: 1572168
Sex: F
Age: 81
State: VA

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itching; soreness in right arm similar to flu shot experience; Some small tightness in my throat and rib cage; This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (Some small tightness in my throat and rib cage), VACCINATION SITE PRURITUS (Itching) and VACCINATION SITE PAIN (soreness in right arm similar to flu shot experience) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L2O4) for COVID-19 vaccination. No Medical History information was reported. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced THROAT TIGHTNESS (Some small tightness in my throat and rib cage). On 14-Jan-2021, the patient experienced VACCINATION SITE PAIN (soreness in right arm similar to flu shot experience). On 16-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching). On 16-Jan-2021, VACCINATION SITE PRURITUS (Itching) and VACCINATION SITE PAIN (soreness in right arm similar to flu shot experience) had resolved. At the time of the report, THROAT TIGHTNESS (Some small tightness in my throat and rib cage) had resolved. The throat tightness lasted for 10 mins The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient drank orange juice for the symptoms.

Other Meds:

Current Illness:

ID: 1572169
Sex: M
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: soreness and pain in neck; high fever; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (soreness and pain in neck) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NECK PAIN (soreness and pain in neck). At the time of the report, NECK PAIN (soreness and pain in neck) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information not provided.

Other Meds:

Current Illness:

ID: 1572170
Sex: F
Age: 47
State: FL

Vax Date: 01/13/2021
Onset Date: 01/14/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore throat; Swollen glands; Tiredness; Chills; Fever; Swollen injection site; This spontaneous case was reported by a consumer and describes the occurrence of in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with IBUPROFEN (ADVIL 12 HOUR) on 14-Jan-2021 for Fever, at a dose of 500 mg. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested

Other Meds:

Current Illness:

ID: 1572171
Sex: F
Age: 49
State:

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a health care professional and describes the occurrence of DIZZINESS POSTURAL (Feeling faint when standing up), PAIN IN EXTREMITY (arm soreness), FATIGUE (feeling tired), NAUSEA (nauseous) and CHILLS (chills) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The patient's past medical history included Postural orthostatic tachycardia syndrome from 2015 to 2018. Concomitant products included ADRENAL SUPPORT for Adrenal insufficiency, LYSINE for Cold sores, ASCORBIC ACID (VITAMIN C CITRUS) for Combined immunity deficiency, CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]), VITAMIN D3, ZINC and FISH OIL for Supplementation therapy. On 11-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm soreness) and FATIGUE (feeling tired). On 14-Jan-2021, the patient experienced DIZZINESS POSTURAL (Feeling faint when standing up), NAUSEA (nauseous) and CHILLS (chills). At the time of the report, DIZZINESS POSTURAL (Feeling faint when standing up), PAIN IN EXTREMITY (arm soreness), FATIGUE (feeling tired), NAUSEA (nauseous) and CHILLS (chills) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Non-Significant Follow-up; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. The patient's concurrent condition of Postural orthostatic tachycardia syndrome remains a confounder.

Other Meds: VITAMIN B12 [CYANOCOBALAMIN]; VITAMIN D3; VITAMIN C CITRUS; ZINC; FISH OIL; ADRENAL SUPPORT; LYSINE

Current Illness:

ID: 1572172
Sex: M
Age: 76
State: FL

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: feeling some discomfort; Slight itchiness; redness around the site of injection and getting bigger; Pain at site of injection/burning sensation; A spontaneous report was received from other health care professional concerning a 76- year -female patient who received Modena's COVID-19 vaccine (mRNA-1273) and experienced Pain at site of injection/slight burn sensation(injection site pain), redness (Injection site erythema) and slight itchiness (Injection site pruritus) and feeling some discomfort (Injection site discomfort). The patient's medical history was not provided. No relevant concomitant medications were reported. On 4-jan-2021, the patient received their first of two planned doses of mRNA-1273 (lot/batch 025J20A) intramuscularly for prophylaxis of COVID-19 infection. He had pain at the site of injection for 2 days from the day he received it. On 9-jan-2021 he started noticing redness around the site of injection and it seems to be getting bigger. Over the weekend around 16 or 17 of January 2021 he started feeling some discomfort which includes slight burning sensation and itchiness. He had used Benadryl ointment for the affected area since last week, but he still had the symptoms. No laboratory data was provided. No treatment drugs were provided. Action taken with mRNA-1273 in response to the events Pain at site of injection/slight burn sensation (injection site pain), redness (Injection site erythema) and slight itchiness (Injection site pruritus) and feeling some discomfort (Injection site discomfort) was unknown. On an unknown date, the outcome of the event Pain at site of injection/slight burn sensation(injection site pain) was recovered/resolved and the outcome of the events redness (Injection site erythema) and slight itchiness (Injection site pruritus) and feeling some discomfort (Injection site discomfort) was not recovered/not resolved.

Other Meds:

Current Illness:

ID: 1572173
Sex: F
Age: 69
State:

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Discomfort - Near Injection Site; Itchiness - Near Injection site; Tingling Sensation - Near Injection Site; A spontaneous report was received from other health care professional concerning a 69- year -female patient who received Modena's COVID-19 vaccine (mRNA-1273) and experienced some discomfort (vaccination site discomfort), itchiness(vaccination site pruritus), and a tingling sensation (vaccination site par aesthesia) near the injection site. The patient's medical history was not provided. No relevant concomitant medications were reported. On 15-jan-2021, the patient received their first of two planned doses of mRNA-1273 (lot/batch 039K20A) intramuscularly for prophylaxis of COVID-19 infection. He reported that his wife received the first dose of the Moderna COVID-19 Vaccine on 15JAN2021 in her Right upper arm. Patient husband reported that her symptoms began the same day on 15JAN2021. These symptoms include some discomfort, itchiness, and a tingling sensation near the injection site. No laboratory data was provided. No treatment drugs were provided. Action taken with mRNA-1273 in response to the events some discomfort (vaccination site discomfort), itchiness (vaccination site pruritus), and a tingling sensation (vaccination site par aesthesia) near the injection site was unknown. On an unknown date, the outcome of the events some discomfort (vaccination site discomfort), itchiness (vaccination site pruritus), and a tingling sensation (vaccination site par aesthesia) near the injection site was unknown.

Other Meds:

Current Illness:

ID: 1572174
Sex: F
Age:
State: FL

Vax Date: 01/14/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Developed severe dizziness; A spontaneous report was received from other health care professional concerning a 31- year -female patient who received Modena's COVID-19 vaccine (mRNA-1273) and experienced severe dizziness. The patient's medical history was not provided. No relevant concomitant medications were reported. On 14-jan-2021, the patient received their first of two planned doses of mRNA-1273 (lot/batch unknown) intramuscularly for prophylaxis of COVID-19 infection. On 14-jan-2021, patient developed after receiving her first shot of Moderna COVID 19 Vaccine severe dizziness which is still ongoing and would like to know if it is normal. No laboratory data was provided. No treatment drugs were provided. Action taken with mRNA-1273 in response to the event severe dizziness was unknown. On an unknown date, the outcome of the event severe dizziness was not recovered/not resolved.

Other Meds:

Current Illness:

ID: 1572175
Sex: M
Age:
State: CA

Vax Date: 01/07/2021
Onset Date: 01/16/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red rash that was itchy; mild rash 2-3 inch (5-8 cm); A spontaneous report was received from other health care professional concerning a 74- year -female patient who received Modena's COVID-19 vaccine (mRNA-1273) and experienced red rash that was itchy (rash pruritic) and mild rash 2-3inch (5-8 cm) rash erythematous. The patient's medical history was not provided. No relevant concomitant medications were reported. On 7-jan-2021, the patient received their first of two planned doses of mRNA-1273 (lot/batch unknown) intramuscularly on left arm for prophylaxis of COVID-19 infection. Patient said that he got vaccinated with Moderna COVID-19 vaccine on 7-jan-2021 at Lomalinda University and it's all normal no adverse reaction until the 9th day. On 16-jan-2021 he had a red rash on his arm that is about 2-3inch or 5-8CM that is itchy. Said that he did not took any medication to relieve the itchiness but he just scratching it and it is now a little better. No laboratory data was provided. Action taken with mRNA-1273 in response to the events red rash that was itchy (rash pruritic) and mild rash 2-3inch (5-8 cm) rash erythematous was unknown. On an unknown date, the outcome of the events red rash that was itchy (rash pruritic) and mild rash 2-3inch (5-8 cm) rash erythematous was unknown.

Other Meds:

Current Illness:

ID: 1572176
Sex: F
Age:
State: TX

Vax Date: 01/07/2021
Onset Date: 01/17/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm pain; red spot on my arm (size of a dime) where they injected the shot (left arm),; little sore; A spontaneous report was received from a consumer concerning a -female patient of unknown age,who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced pain in arm,vaccination site erythema and vaccination site pain. The patient's medical history was not provided.No relevant concomitant medications were reported. On 7-jan-2021,prior to the onset of the events, the patient received their planned dose of mRNA-1273 (lot/batch unknown) intramuscularly on left arm for prophylaxis of COVID-19 infection. On 17-jan-2021,the patient experienced a red spot on arm (size of a dime) where they injected the shot (left arm) and a little sore. No laboratory data was provided.Treatment information was not provided. Action taken with mRNA-1273 in response to the events was unknown. The outcome of the events pain in arm,vaccination site erythema and vaccination site pain was considered as not resolved at the time of the report.

Other Meds:

Current Illness:

ID: 1572177
Sex: F
Age: 41
State: TX

Vax Date: 01/10/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore at the site of injection; Redness at the injection site; Warm touch at the injection site; A spontaneous report (United States) was received from consumer concerning a 41-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced sore at the injection site/Pain, Redness at the injection site/Redness and warm touch at the injection site/ Warmth. The patient's medical history was not provided. No relevant concomitant medications were reported. No information on allergies were provided. The reported stated that the patient was physically and mentally healthy before vaccination. On 10 Jan 2021 , prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number:025L20A) via unknown route at unknown location for prophylaxis of COVID-19 infection. Patient experienced soreness, redness, and warm to ouch at the injection site on 11 Jan 2021 after taking the first dose of vaccine. Tylenol and Advil were used as treatment medication by the patient. Consent was given for the follow up by the patient. Action taken with mRNA-1273 in response to the events was not reported. The outcome for the events injection site pain, Redness at the injection site and injection site warmth was considered unknown.

Other Meds:

Current Illness:

ID: 1572178
Sex: M
Age: 81
State: CA

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Cough; sore arm; Headache; A spontaneous report was received from a consumer concerning a 81- year old-male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced pain in arm,cough and headache. The patient's medical history was not provided.No relevant concomitant medications were reported. On 15-jan-2021,prior to the onset of the events, the patient received their planned dose of mRNA-1273 (lot/batch 029L20A) on left arm for prophylaxis of COVID-19 infection. On 16-jan-2021,the patient developed a cough and experienced a sore arm and a headache. No laboratory data was provided.Treatment information included,cough syrup was reported. Action taken with mRNA-1273 in response to the events was unknown. The outcome of the events cough,pain in arm and headache was considered as not resolved at the time of the report.

Other Meds:

Current Illness:

ID: 1572179
Sex: F
Age:
State: TX

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pink; swollen; hurts in the muscle; felt tired; Hurt; A spontaneous report was received from a consumer concerning a 64- year old-female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced vaccination site discolouration,pain,injection site pain,injection site swelling and fatigue. The patient's medical history was not provided.concomitant medications included,fexofenadine hydrochloride was reported. On 07-jan-2021,prior to the onset of the events, the patient received their planned dose of mRNA-1273 (lot/batch unknown) through an unknown route on her arm for prophylaxis of COVID-19 infection. On 17-jan-2021,the patient got her injection site swollen and pink and it hurts in the muscle.she initially got vaccinated she just felt tired and hurt but she got well until the reaction that appeared tonight.No laboratory data was provided.Treatment information included,ice pack was reported. Action taken with mRNA-1273 in response to the events was unknown. The outcome of the events vaccination site discolouration,pain,injection site pain,injection site swelling and fatigue was considered as unknown at the time of the report.

Other Meds: ALLEGRA

Current Illness:

ID: 1572180
Sex: F
Age: 64
State: CA

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Heart started racing rapidly; Felt dizzy; Eyes felt like swelling; Still feeling bad since the shot; Could not catch her breath; A spontaneous report (United States) was received from a consumer concerning herself, a 64-year-old patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced rapid racing of her heart / palpitation, felt dizzy, eyes felt like swelling, could not catch her breath / dysnopea and was still feeling bad since the shot / feeling abnormal. The patient's medical history was not reported. Concomitant medications reported included thyroid medications, Escitalopram oxalate, Pravastatin, Trazodone and vitamins. On 21 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 042L20A) in the arm for prophylaxis of COVID-19 infection. The route of administration was not provided. On 21 Jan 2021, as soon as she was injected her heart started racing rapidly, felt dizzy, her eyes felt like swelling and she could not catch her breath. A nurse at the facility spoke to her and calmed her down but she was still feeling bad since the shot. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of events, heart started racing rapidly, felt dizzy, her eyes felt like swelling and she could not catch her breath resolved on 21 Jan 2021. The outcome of the event, feeling bad since the shot was not resolved at the time of report.

Other Meds: THYROID; LEXAPRO; PRAVASTATIN; TRAZODONE; VITAMINS NOS

Current Illness:

ID: 1572181
Sex: M
Age:
State: KY

Vax Date: 01/07/2021
Onset Date: 01/15/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen armpit lymph nodes; A spontaneous report was received from a consumer, concerning a male patient of 32 age, who received ModernaCOVID-19 vaccine . The patient's medical history was not provided. Concomitant product code was provided as finasteride 1mg. On an 7-jan-2021 , the patient received their first of two planned doses of mRNA-1273 at Hospital.(lot number unknown) via unknow route of administration. Said that 1/15/21 9 days after the vaccination the patient had swollen armpit lymph nodes patient never had any adverse reaction after being vaccinated not until 9 days after. Action taken with mRNA-1273 in response to the event was unknown. The outcome of the event, shingles was considered to be not resolved at the time of this report.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds: FINASTERIDE

Current Illness:

ID: 1572182
Sex: F
Age: 84
State: NY

Vax Date: 01/16/2021
Onset Date: 01/17/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Indigestion; Chills; Vomiting; A spontaneous report was received from a consumer concerning an 84-year-old female who experienced indigestion, chills and vomiting. The patient's medical history was not provided. Concomitant product use was not provided. On 16-Jan-2021, approximately 1 day prior to onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 070821) intramuscularly for prophylaxis of COVID-19 infection. On 17-Jan-2021 patient experienced indigestion, chills, and vomiting. Treatment for indigestion included self-administered bismuth subsalicylate. Treatment for chills and vomiting was unknown. Action taken with mRNA-1273 in response to the event was unknown. The events, chills and vomiting were considered recovered/resolved. The outcome of the event of indigestion was unknown.

Other Meds:

Current Illness:

ID: 1572183
Sex: M
Age: 63
State: TX

Vax Date: 01/12/2021
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection Site hive; The Injection area was a little itchy like a 1 out of 10; little Redness on the injection site; Muscle Pain; A spontaneous report was received from a consumer who was also a 63-years-old male patient who received Moderna's COVID-19 vaccine and experienced redness on the Injection Site, and Muscle Pain, hives began around the injection area looking like little bumps and pink color and the hives were more visible, little itchy. Patient's medical history was not provided, and concomitant medicines taken by the patient, Azithromycin 250mg from January 5th until January 10th (Prescribed by his Physician). 2 days before the vaccination. On 12 JAN 2021, approximately, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 13 Jan 2021, the patient started to experience following redness on the Injection Site, and Muscle Pain, hives began around the injection area looking like little bumps and pink color and the hives were more visible, little itchy. Treatment included Benadryl By mouth, Famotidine By Mouth, Hydrocortisone 1% Cream by topical route 63 years old male patient calling to report that he had the Moderna COVID-19 Vaccine on 12JAN2021 in the deltoid muscle of the left arm. The next day he had a little Redness on the Injection Site, and Muscle Pain. On 14JAN2021 the redness disappeared. On 15JAN2021 hives began around the injection area looking like little bumps and pink color and the hives were more visible on 16JAN2021. The Injection area was a little itchy like a 1 out of a scale of 1 to 10. Today 17JAN2021 The Injection Site hive is still going on but not as visible. He reported, "I took Benadryl, and acid reflux medicine Famotidine (heard it is good for hives). Applied Hydrocortisone 1% cream on it as per my pharmacist recommendation." Action taken with mRNA-1273 was not reported. The outcome of the events, redness on the Injection Site, and Muscle Pain, hives began around the injection area looking like little bumps and pink color and the hives were more visible, little itchy, was considered not recovered/resolved

Other Meds:

Current Illness:

ID: 1572184
Sex: M
Age:
State:

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: heaviness in breathing/shortness of breath; A spontaneous report was received from a consumer concerning a male patient of unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the event, heaviness in breathing/shortness of breath. The patient's medical history was not provided. No relevant concomitant medications were reported. On 11/Jan/2021, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection. On 12-JAN-2021, the patient experienced event, heaviness in breathing/shortness of breath. No treatment information was provided. Action taken with mRNA-1273 in response to the event, heaviness in breathing/shortness of breath was not reported. On 13-JAN-2021, the outcome of event, heaviness in breathing/shortness of breath was recovered.

Other Meds:

Current Illness:

ID: 1572185
Sex: F
Age: 70
State: NY

Vax Date: 01/17/2021
Onset Date: 01/18/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; A spontaneous report was received from a consumer concerning 70 years old, female patient who experienced Sore arm. The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, Concomitant product use was not provided by the reporter. The patient received their first of two planned doses of mRNA-1273 (Batch number: 012620A on 17-Jan-2021 intramuscularly in the left arm for prophylaxis of COVID-19 infection. The patient experienced Sore arm since 18-Jan-2021. Treatment information was unknown. Action taken with mRNA-1273 in response to the event(s) was unknown. The outcome of the reported event Sore arm was not reported. Company Comment: The reported event, Sore arm was considered possible to mRNA-1273.

Other Meds:

Current Illness:

ID: 1572186
Sex: F
Age: 51
State: OH

Vax Date: 12/24/2020
Onset Date: 12/24/2020
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: the arm where I received the shot is sore; A spontaneous report \was received from a Consumer concerning a ? 51-Years old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced soreness on left arm where she received the shot. The patient's medical history was not provided. No relevant concomitant medications were reported. On 24th Dec 2020, prior to the onset of the event, the patient received their first of dose of mRNA-1273 (lot/Batch No: 039K20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 24th Dec 2020, the patient experienced the soreness on her left arm where she received vaccine. Laboratory details not provided. She used to treat with Bengay on the area for soreness. Action taken with mRNA-1273 in response to the events was not reported.

Other Meds:

Current Illness:

ID: 1572187
Sex: F
Age: 31
State: OH

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 3hs after vaccination she felt lots of itching, diffused all over her body; 1 hive, very small on her neck; A spontaneous report was received from a nurse concerning a 31 years old, female patient who experienced itching all over and hive on her neck. The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, Concomitant product use was not provided by the reporter. On 31-Dec-2020, approximately 3 hours prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 026L20A ) intramuscularly for prophylaxis of COVID-19 infection. The patient experienced itching all over the body and hive on neck since 31-Dec-2020.Treatment for the event included [List all drug and non-drug therapies administered to treat the event] OR Treatment information was not provided/unknown. Action taken with mRNA-1273 in response to the event(s) was not provided/unknown. The event(s), itching all over and hive on neck, were considered recovered/resolved on 02-Jan-2021.

Other Meds:

Current Illness:

ID: 1572188
Sex: F
Age:
State: CA

Vax Date: 01/17/2021
Onset Date: 01/17/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Minimal swelling of her throat; A spontaneous report was received from a physician, concerning a female patient of unspecified age, who received Moderna's COVID-19 Vaccine and experienced minimal swelling of her throat. The patient's medical history was not provided. Concomitant product use was not provided. On 17-Jan-2021, prior to the onset of event, the patient received the first of two planned doses of mRNA-1273 (batch number 41620A) intramuscularly for COVID-19 infection prophylaxis. On 17-Jan-2021, the patient complained of minimal swelling of her throat. The swelling got resolved in about an hour and there was no effect on respiration. The patient did not seek medical attention or treatment. Reporter denied consent to follow-up. Action taken with mRNA-1273 in response to the event was not provided. The event, minimal swelling of her throat, was considered resolved on 17-Jan-2021.; Reporter's Comments: This spontaneous report concerns a female patient who experienced an event of minimal swelling of her throat. The event occurred on the same day after the administration of the first dose of the vaccine mRNA-1273 vaccine (Lot #: 41620A, expiration date-Unknown). No treatment was administered and the event resolved 1 hour later. Based on the information provided, which includes a strong temporal association between the reported event of minimal swelling of her throat and the administration of mRNA-1273 vaccine, a causal association cannot be excluded.

Other Meds:

Current Illness:

ID: 1572189
Sex: M
Age: 77
State:

Vax Date: 01/24/2021
Onset Date: 01/24/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headache; nausea; Fever 100 degrees; A spontaneous report was received from a consumer concerning herself a male patient of age 78-years-old received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a headache, nausea and a fever 100 Degrees. The patient's medical history was not provided. Concomitant medications were not reported by reporter. On 24 Jan 2021, prior to the onset of the events the patient received his first of two planned doses of mRNA-1273 (lot/batch:030L20A) intramuscularly for prophylaxis of COVID-19 infection. After vaccination he experienced headache, nausea and a fever 100 Degrees and want to know whether he can take Tylenol, but he said he is feeling better now. Action taken with mRNA-1273 in response to the events was unknown. On unknown date the outcome of event(s), headache, nausea and a fever 100 Degrees was resolve

Other Meds:

Current Illness:

ID: 1572190
Sex: F
Age: 60
State: IL

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: inflammatory response; sore arm; redness; rash; A spontaneous report was received from a health care professional concerning about a 60 years old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events rash, redness/erythema, pain in arm/pain in extremity and inflammatory reaction/inflammation. The patient's medical history was reported as have hypothyroidism. Concomitant medications were reported as having medication levothyroxine sodium. On 05 Jan 2021, prior to the onset of the events, the patient received their first planned doses of mRNA-1273 (Batch number: 026L20A) via intramuscular in left deltoid for the prophylaxis of COVID-19 infection. On 05 Jan 2021, same day of vaccination the patient experienced events sore arm, redness and rash. On 15 Jan 2021, the rashes came back. On 17 Jan 2021, patient seeks medical consult and advised that rash might be an inflammatory response and a beginning of cellulitis (not certain). Laboratory details was not provided. Treatment information was provided as patient prescribed to take hydrocortisone steroid cream, anti-bacterial cream and benadryl. On 06 Jan 2021, the events sore arm, redness and rash resolved. Action taken with mRNA-1273 in response to the events are unknown. The outcomes of the event which reappeared remain unknown.

Other Meds: SYNTHROID

Current Illness: Hypothyroidism

ID: 1572191
Sex: F
Age: 43
State: TX

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; Diarrhea; Gas; Stomach Rumbling; Nausea; Severe Injection Site Pain; This spontaneous case was reported by an occupational therapist and describes the occurrence of DIARRHOEA (Diarrhea), FLATULENCE (Gas), ABDOMINAL DISCOMFORT (Stomach Rumbling), NAUSEA (Nausea) and INJECTION SITE PAIN (Severe Injection Site Pain) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced DIARRHOEA (Diarrhea), FLATULENCE (Gas), ABDOMINAL DISCOMFORT (Stomach Rumbling), NAUSEA (Nausea) and INJECTION SITE PAIN (Severe Injection Site Pain). On 16-Jan-2021, the patient experienced HEADACHE (Headache). On 15-Jan-2021, INJECTION SITE PAIN (Severe Injection Site Pain) had resolved. On 16-Jan-2021, HEADACHE (Headache) had resolved. At the time of the report, DIARRHOEA (Diarrhea), FLATULENCE (Gas), ABDOMINAL DISCOMFORT (Stomach Rumbling) and NAUSEA (Nausea) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided. Reporter did not allow further contact; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.

Other Meds:

Current Illness:

ID: 1572192
Sex: F
Age: 78
State: NJ

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: rash on left side of the face; chills in her hands; Case reference number MOD-2021-008781 is a spontaneous case report sent by a Non-Health Professional on 18-JAN-2021, which refers to a Female aged 78 Years . On 15Jan2021 the patient started taking Moderna COVID-19 Vaccine for COVID-19 vaccination. 2 days later, the patient developed chills in her hands, the patient also developed rash on left side of the face. The Non-Health Professional did not declare any relatedness between chills in her hands and Moderna COVID-19 Vaccine In their opinion, PMH includes Covid infection in May2020. No further information provided. Caller consents to follow up. The medical reviewer may provide a case evaluation statement, including other possible etiological and confounding factors, e.g. (only limited information has been obtained so far, it is difficult to assess the cause and effect relationship; the co-medications y and x should also be considered causative as the reported event is labeled for both drugs; the company's view is the event is not due to the drug for the following reasons ? (probably due to pre existing disease); there is no plausible mechanism to implicate the drug. . Terse Narrative (for PSUR narratives and signal review) Brief 3 line summary of above for CIOMS listing: Report Source- Non-Health Professional, Age- 78 Years, Sex- Female, Suspect Drug- Moderna COVID-19 Vaccine, Treatment- Diagnosis\Outcome- .

Other Meds:

Current Illness:

ID: 1572193
Sex: F
Age: 48
State: WI

Vax Date: 01/10/2021
Onset Date: 01/10/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Bruise at injection site; Sore arm; Puffy at injection site; Slight headache; A spontaneous report was received from a HCP and Consumer concerning a 48 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events: headache, injection site pain, vaccination site swelling, vaccination site bruising. The patient's medical history was not provided. Relevant concomitant medications include Thyroid pill. On 10JAN2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the left arm for prophylaxis of COVID-19 infection. Patient stated that, on 10 JAN 2021, she had a slight headache through night. On 11 JAN 2021, she also experienced sore arm, puffy at the injection site. lastly, around the 14 JAN 2021, she started noticing there was a bruise. She wanted to know whether she should take the vaccine in the same arm are or not Laboratory details were not provided. The patient took Ibuprofen for the treatment of symptoms. Action taken with mRNA-1273 in response to the events was not reported. On date, the outcome of the events: headache, injection site pain, vaccination site swelling, vaccination site bruising was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds: THYROID

Current Illness:

ID: 1572194
Sex: F
Age: 33
State: NJ

Vax Date: 01/06/2021
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tested positive for COVID-19; congestion; runny nose; Muscle pain; chills; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19), NASAL CONGESTION (congestion), RHINORRHOEA (runny nose), MYALGIA (Muscle pain) and CHILLS (chills) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. No Medical History information was reported. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19), NASAL CONGESTION (congestion), RHINORRHOEA (runny nose), MYALGIA (Muscle pain) and CHILLS (chills). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19), NASAL CONGESTION (congestion), RHINORRHOEA (runny nose), MYALGIA (Muscle pain) and CHILLS (chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided

Other Meds:

Current Illness:

ID: 1572195
Sex: F
Age: 79
State: MI

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: GERD acting up; Ice cold feeling her chest; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE (GERD acting up) and FEELING COLD (Ice cold feeling her chest) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The patient's past medical history included GERD on 15-Jan-2021 and Acute bronchitis on 15-Jan-2021. On 15-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (GERD acting up) and FEELING COLD (Ice cold feeling her chest). On 15-Jan-2021, GASTROOESOPHAGEAL REFLUX DISEASE (GERD acting up) and FEELING COLD (Ice cold feeling her chest) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. Treatment included a heating pad.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.

Other Meds:

Current Illness:

ID: 1572196
Sex: M
Age: 86
State: GA

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: After I went to bed, I had to get up to urinate every 15 minutes and it is still occuring today; A spontaneous report (United States) was received from a consumer concerning a 86? Years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the event, after I went to bed, I had to get up to urinate every 15 minutes and it is still occuring today. The patient's medical history was not provided. No relevant concomitant medications were reported. On 18/Jan/2021, the patient received their first of two planned doses of mRNA-1273 (lot/batch: or unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 18-JAN-2021, the patient experienced event, after I went to bed, I had to get up to urinate every 15 minutes and it is still occuring today. No treatment information was provided. Action taken with mRNA-1273 in response to the event, after I went to bed, I had to get up to urinate every 15 minutes and it is still occuring today was not reported. On an unknown date the outcome of event, after I went to bed, I had to get up to urinate every 15 minutes and it is still occuring today was unknown.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 559,999

Page last modified: 03 October 2021 5:28pm